title: Antilipolytic effect of calcimimetics depends on the allelic variant of calcium-sensing receptor gene polymorphism rs1042636 (Arg990Gly).
abstract: Calcium-sensing receptor polymorphism rs1042636 (Arg990Gly) affects the response to the calcimimetic cinacalcet, used to treat hypercalcemia in secondary hyperparathyroidism (sHPT) or parathyroid carcinoma. Carriers of the Arg allelle, show less parathyroid hormone secretion suppression in response to the drug. This effect was reproducible in transfected cultured human embryonic kidney cells, supporting a causal relationship on the protein level. We previously established that cinacalcet has an antilipolytic effect in isolated human adipocytes; however, there were a number of samples that did not respond to the treatment. The present work aimed to investigate whether the variable antilipolytic response to cinacalcet in adipocytes was consistent with the effect reported for the rs1042636 polymorphism. Lipolysis was assessed by measuring glycerol release after exposure to cinacalcet (10 μM) or vehicle in adipocytes isolated from 38 donors. Responsiveness was defined as lipolysis suppression (cinacalcet vs vehicle control) greater than 20%. Genotype analysis showed that 23 adipocyte donors were homozygous for Arg at position 990, 14 heterozygous and 1 homozygous Gly-Gly. Among the Arg homozygotes, one was responsive to cinacalcet, whereas five Gly carriers responded to the calcimimetic. In all, 83% of adipocytes showing response to cinacalcet carried the glycine allele, whereas in 96% of Arg-Arg individuals adipocytes did not respond to the calcimimetic (P=0.027, Fisher's exact test). Confirming sHPT observations, adipocytes from rs1042636 Gly-allele carriers show higher sensitivity to the antilipolytic action of cinacalcet. The potential benefit of cinacalcet as a suppressor of basal lipolysis and free fatty acid release in uremic patients needs to consider the rs1042636 single-nucleotide polymorphism.
authors.affiliation: Institute of Nutrition and Food Technology (INTA), University of Chile, Avenue El Líbano 5524, Santiago, Chile.
authors.forename: Marcela
authors.initials: M
authors.lastname: Reyes
authors.forename: Hansjörg M
authors.initials: HM
authors.lastname: Rothe
authors.forename: Pamela
authors.initials: P
authors.lastname: Mattar
authors.forename: Warren B
authors.initials: WB
authors.lastname: Shapiro
authors.forename: Mariana
authors.initials: M
authors.lastname: Cifuentes
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D002118:Calcium / Q000378:metabolism*; D000069449:Cinacalcet; D014644:Genetic Variation; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000235:genetics; D008875:Middle Aged; D009281:Naphthalenes / Q000494:pharmacology; D011110:Polymorphism, Genetic; D044169:Receptors, Calcium-Sensing / Q000235:genetics*
chemical_list: D009281:Naphthalenes; D044169:Receptors, Calcium-Sensing; D002118:Calcium; D000069449:Cinacalcet